- Home
- BDTX vs ATOM Comparison
BDTX vs ATOM Comparison
Compare BDTX & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- ATOM
- Stock Information
- Founded
- BDTX 2014
- ATOM 2001
- Country
- BDTX United States
- ATOM United States
- Employees
- BDTX N/A
- ATOM N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ATOM Semiconductors
- Sector
- BDTX Health Care
- ATOM Technology
- Exchange
- BDTX Nasdaq
- ATOM Nasdaq
- Market Cap
- BDTX 132.5M
- ATOM 155.4M
- IPO Year
- BDTX 2020
- ATOM 2016
- Fundamental
- Price
- BDTX $2.58
- ATOM $5.05
- Analyst Decision
- BDTX Strong Buy
- ATOM Strong Buy
- Analyst Count
- BDTX 6
- ATOM 1
- Target Price
- BDTX $14.83
- ATOM $7.00
- AVG Volume (30 Days)
- BDTX 1.3M
- ATOM 561.6K
- Earning Date
- BDTX 08-05-2025
- ATOM 07-29-2025
- Dividend Yield
- BDTX N/A
- ATOM N/A
- EPS Growth
- BDTX N/A
- ATOM N/A
- EPS
- BDTX 0.09
- ATOM N/A
- Revenue
- BDTX $70,000,000.00
- ATOM $121,000.00
- Revenue This Year
- BDTX N/A
- ATOM $202.22
- Revenue Next Year
- BDTX N/A
- ATOM $1,225.00
- P/E Ratio
- BDTX $29.29
- ATOM N/A
- Revenue Growth
- BDTX N/A
- ATOM N/A
- 52 Week Low
- BDTX $1.20
- ATOM $2.31
- 52 Week High
- BDTX $6.75
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- BDTX 60.64
- ATOM 41.61
- Support Level
- BDTX $2.43
- ATOM $4.85
- Resistance Level
- BDTX $2.72
- ATOM $5.17
- Average True Range (ATR)
- BDTX 0.18
- ATOM 0.28
- MACD
- BDTX -0.00
- ATOM -0.02
- Stochastic Oscillator
- BDTX 76.11
- ATOM 36.67
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.